Table 2.
Participant characteristics (N=212).
| Characteristics | Study conditions | |||||||||||
|
|
IPa+CMb (n= 56) | IP (n=55) | CM (n=53) | SRc (n=48) | Total | P value | ||||||
| Host study ClinicalTrials.gov ID, n (%) | .88 | |||||||||||
|
|
NCT03169101 | 25 (44.6) | 23 (41.8) | 23 (43.4) | 19 (39.6) | 90 (42.5) |
|
|||||
|
|
NCT03384784 | 13 (23.2) | 14 (25.5) | 12 (22.6) | 15 (31.3) | 54 (25.5) |
|
|||||
|
|
NCT03438188 | 12 (21.4) | 15 (27.3) | 14 (26.4) | 8 (16.7) | 49 (23.1) |
|
|||||
|
|
NCT02837510 | 6 (10.7) | 3 (5.5) | 4 (7.6) | 6 (12.5) | 19 (9) |
|
|||||
| Sex (male), n (%) | 35 (62.5) | 34 (61.8) | 39 (73.6) | 33 (68.8) | 141 (66.5) | .52 | ||||||
| Age (years), mean (SD) | 48 (11.9) | 52.3 (9.4) | 52.1 (9.2) | 48.3 (12) | 50.2 (10.8) | .06 | ||||||
| Race, n (%) | .14 | |||||||||||
|
|
White | 15 (26.8) | 8 (14.6) | 12 (22.6) | 11 (22.9) | 46 (21.7) |
|
|||||
|
|
African American or Black | 37 (66.1) | 46 (83.6) | 38 (71.7) | 30 (62.5) | 151 (71.2) |
|
|||||
|
|
Asian | 0 (0) | 0 (0) | 1 (1.9) | 1 (2.1) | 2 (0.9) |
|
|||||
|
|
More than 1 race | 3 (5.4) | 1 (1.8) | 2 (3.8) | 1 (2.1) | 7 (3.3) |
|
|||||
|
|
Unknown | 1 (1.8) | 0 (0) | 0 (0) | 4 (8.3) | 5 (2.4) |
|
|||||
|
|
Refused | 0 (0) | 0 (0) | 0 (0) | 1 (2.1) | 1 (0.5) |
|
|||||
| Ethnicity, n (%) | .03d | |||||||||||
|
|
Hispanic | 2 (3.6) | 3 (5.5) | 1 (1.9) | 7 (14.6) | 13 (6.13) |
|
|||||
|
|
Non-Hispanic | 54 (96.4) | 52 (94.6) | 50 (94.3) | 41 (86.4) | 197 (92.9) |
|
|||||
|
|
Unknown | 0 (0) | 0 (0) | 2 (3.8) | 0 (0) | 2 (0.9) |
|
|||||
| Smoking status (smoker), n (%) | 50 (89.3) | 47 (85.5) | 44 (83) | 37 (77.1) | 178 (84) | .39 | ||||||
| HIV status (HIV+), n (%) | 22 (40) | 21 (39.6) | 25 (50) | 24 (50) | 92 (44.7) | .54 | ||||||
aIP: information provision.
bCM: contingency management.
cSR: standard recruitment.
dP<.05.